These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37699927)

  • 1. The H163A mutation unravels an oxidized conformation of the SARS-CoV-2 main protease.
    Tran N; Dasari S; Barwell SAE; McLeod MJ; Kalyaanamoorthy S; Holyoak T; Ganesan A
    Nat Commun; 2023 Sep; 14(1):5625. PubMed ID: 37699927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton-Coupled Conformational Activation of SARS Coronavirus Main Proteases and Opportunity for Designing Small-Molecule Broad-Spectrum Targeted Covalent Inhibitors.
    Verma N; Henderson JA; Shen J
    J Am Chem Soc; 2020 Dec; 142(52):21883-21890. PubMed ID: 33320670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtual Alanine Scan of the Main Protease Active Site in Severe Acute Respiratory Syndrome Coronavirus 2.
    Nakayoshi T; Kato K; Kurimoto E; Oda A
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based lead optimization of herbal medicine rutin for inhibiting SARS-CoV-2's main protease.
    Huynh T; Wang H; Luan B
    Phys Chem Chem Phys; 2020 Nov; 22(43):25335-25343. PubMed ID: 33140777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unmasking the Conformational Stability and Inhibitor Binding to SARS-CoV-2 Main Protease Active Site Mutants and Miniprecursor.
    Kovalevsky A; Coates L; Kneller DW; Ghirlando R; Aniana A; Nashed NT; Louis JM
    J Mol Biol; 2022 Dec; 434(24):167876. PubMed ID: 36334779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery.
    Ray AK; Sen Gupta PS; Panda SK; Biswal S; Bhattacharya U; Rana MK
    Comput Biol Med; 2022 Mar; 142():105183. PubMed ID: 34986429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoprocessing and oxyanion loop reorganization upon GC373 and nirmatrelvir binding of monomeric SARS-CoV-2 main protease catalytic domain.
    Nashed NT; Kneller DW; Coates L; Ghirlando R; Aniana A; Kovalevsky A; Louis JM
    Commun Biol; 2022 Sep; 5(1):976. PubMed ID: 36114420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using serpins cysteine protease cross-specificity to possibly trap SARS-CoV-2 Mpro with reactive center loop chimera.
    Jairajpuri MA; Ansari S
    Clin Sci (Lond); 2020 Sep; 134(17):2235-2241. PubMed ID: 32869854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A yeast-based system to study SARS-CoV-2 Mpro structure and to identify nirmatrelvir resistant mutations.
    Ou J; Lewandowski EM; Hu Y; Lipinski AA; Aljasser A; Colon-Ascanio M; Morgan RT; Jacobs LMC; Zhang X; Bikowitz MJ; Langlais PR; Tan H; Wang J; Chen Y; Choy JS
    PLoS Pathog; 2023 Aug; 19(8):e1011592. PubMed ID: 37651467
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Huynh T; Wang H; Luan B
    J Phys Chem Lett; 2020 Jun; 11(11):4413-4420. PubMed ID: 32406687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conserved interactions required for inhibition of the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
    Shitrit A; Zaidman D; Kalid O; Bloch I; Doron D; Yarnizky T; Buch I; Segev I; Ben-Zeev E; Segev E; Kobiler O
    Sci Rep; 2020 Nov; 10(1):20808. PubMed ID: 33257760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the mechanism of SARS-CoV-2 main protease autocatalytic maturation from model precursors.
    Aniana A; Nashed NT; Ghirlando R; Coates L; Kneller DW; Kovalevsky A; Louis JM
    Commun Biol; 2023 Nov; 6(1):1159. PubMed ID: 37957287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design.
    Yu W; Wu X; Zhao Y; Chen C; Yang Z; Zhang X; Ren J; Wang Y; Wu C; Li C; Chen R; Wang X; Zheng W; Liao H; Yuan X
    Molecules; 2021 Dec; 26(23):. PubMed ID: 34885967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depicting the inhibitory potential of polyphenols from
    Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
    J Biomol Struct Dyn; 2022 Jun; 40(9):4110-4121. PubMed ID: 33292085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biflavonoids from
    Lokhande K; Nawani N; K Venkateswara S; Pawar S
    J Biomol Struct Dyn; 2022 Jul; 40(10):4376-4388. PubMed ID: 33300454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolutionary aspects of mutation in functional motif and post-translational modifications in SARS-CoV-2 3CLpro (Mpro): an in-silico study.
    Gupta A; Sahu N; Singh VK; Sinha RP
    J Proteins Proteom; 2023 Apr; ():1-11. PubMed ID: 37361001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Surveillance of SARS-CoV-2 M
    Lee JT; Yang Q; Gribenko A; Perrin BS; Zhu Y; Cardin R; Liberator PA; Anderson AS; Hao L
    mBio; 2022 Aug; 13(4):e0086922. PubMed ID: 35862764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 main protease cleaves MAGED2 to antagonize host antiviral defense.
    Ju X; Wang Z; Wang P; Ren W; Yu Y; Yu Y; Yuan B; Song J; Zhang X; Zhang Y; Xu C; Tian B; Shi Y; Zhang R; Ding Q
    mBio; 2023 Aug; 14(4):e0137323. PubMed ID: 37439567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of potential plant-based inhibitor against viral proteases of SARS-CoV-2 through molecular docking, MM-PBSA binding energy calculations and molecular dynamics simulation.
    Gogoi B; Chowdhury P; Goswami N; Gogoi N; Naiya T; Chetia P; Mahanta S; Chetia D; Tanti B; Borah P; Handique PJ
    Mol Divers; 2021 Aug; 25(3):1963-1977. PubMed ID: 33856591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors.
    Jiménez-Alberto A; Ribas-Aparicio RM; Aparicio-Ozores G; Castelán-Vega JA
    Comput Biol Chem; 2020 Oct; 88():107325. PubMed ID: 32623357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.